Heron Therapeutics, Inc.
XNAS:HRTX
1.16
$1.22 - 52.00
$1.10 - 2,000.00
$1.11
$1.17
$1.12
$1.12
2.68
1
764342
2014075.3
181643238.42
Chart
TendieTensor AI Analysis
Company
Heron Therapeutics Inc is a commercial-stage biotechnology company. It is focused on improving the lives of patients by developing treatments that address some of the unmet patient needs. The company's product portfolio consists of APONVIE, SUSTOL, ZYNRELEF, and CINVANTI.
Fundamentals
122
-14.340000
30.279300
-0.04
100
BBG000G2GJT7
BBG001SB92D4
183.31M
183.36M
Technicals
Short Interest
—
—
—
Higher = harder to cover
—
Prev: —
—
—
5D avg: —
—
Discussion
Login to participate in discussions.
Recent News
Related Stocks
Based on the portfolios of people who own HRTX. This is a list generated by trading data from 3rd party trading platforms, and it's not a recommendation.